About the job
Invivyd, Inc. develops solutions aimed at protecting immunocompromised individuals from severe viral diseases, with a primary focus on SARS-CoV-2. The company’s technology platform supports the creation and refinement of advanced antibodies. In March 2024, Invivyd received emergency use authorization from the U. S. FDA for a monoclonal antibody in its pipeline. By October 2025, the FDA approved the company’s Investigational New Drug application, allowing further clinical development of VYD2311, a monoclonal antibody being studied as a potential alternative to vaccines for COVID-19 prevention.
Location and Work Arrangement
This Regulatory Affairs Manager role is based in New Haven, CT, with a preference for candidates located in the Northeast region. The position offers a hybrid schedule, combining remote work with regular in-office days at Invivyd’s New Haven headquarters.
